JAMES R. RAMSEY, PH.D., PRESIDENT UNIVERSITY OF LOUISVILLE, JOINS ADVANCED CANCER THERAPEUTICS BOARD OF DIRECTORS


Contact:
Randall B. Riggs, President & CEO
Advanced Cancer Therapeutics
Phone: (502) 345-8911
Email:
rriggs@advancedact.com


FOR IMMEDIATE RELEASE


Louisville, KY - September 24, 2008 - Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market,today announced that James R. Ramsey, Ph.D. has joined its board of directors. A frequent national speaker and writer on economic issues, Dr. Ramsey is the president of the University of Louisville.


“We are honored to have Dr. Ramsey join our board of directors,” said Dale J. Boden, Chairman of the Board of ACT.  “Dr. Ramsey brings a unique combination of economic and public policy experience which will be invaluable in guiding the Company as we continue to advance our pipeline of anti-cancer products closer to human clinical trials.”


Dr. Ramsey has served as president of the University of Louisville since late 2002. During the previous 20 years, he held a variety of positions within the Commonwealth of Kentucky’s public sector, including most recently, Interim Commissioner of the Office of the New Economy, Senior Policy Advisor/State Budget Director and Chief State Economist for the Commonwealth.


“I am pleased to join the ACT board at this exciting time,” said Dr. Ramsey.  “I look forward to contributing my experience to the development of the Company as it works to bring novel anti-cancer therapeutics to the patients who need them.”


Dr. Ramsey earned his Ph.D. in Economics from the University of Kentucky.


About Advanced Cancer Therapeutics (ACT):


ACT is a privately held company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative business model with the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center) whereby ACT is able to obtain exclusive worldwide licenses to novel cancer therapeutics discovered at Brown Cancer Center under preset business terms. ACT then fast-tracks these discoveries, including the selection process for partnership, commercialization and manufacture, to the pharmaceutical industry, and ultimately to the patients who need them. Led by Dr. Don Miller, the Brown Cancer Center employs over fifty scientists focused on the discovery and advancement of breakthrough cancer therapeutics for patients suffering from cancer. For more information, please visit www.advancedcancertherapeutics.com.